Pfizer invests in GLP-1 drug pipeline
PFE
Statements (4)
- Bullish
Pfizer is acquiring companies it believes will position it for strong growth in the GLP-1 market
- Neutral
Drugmakers are introducing GLP-1 pills for obesity treatment.
- Bullish
Pfizer is investing in weight-loss drugs to power its next decade
- Bearish
Pfizer is behind in the GLP-1 weight-loss drug race.